Natera Genetics
@natera.com
Our cell-free DNA tests help inform more personalized health care decisions 🧬
Together with Quantum Leap Healthcare Collaborative, we’re excited to share that new findings from the I-SPY 2 trial were published in Nature Communications. This publication shows Signatera™ can predict treatment response and recurrence risk in early-stage breast cancer. https://ow.ly/BYZR50XKpKV
December 16, 2025 at 4:21 PM
Together with Quantum Leap Healthcare Collaborative, we’re excited to share that new findings from the I-SPY 2 trial were published in Nature Communications. This publication shows Signatera™ can predict treatment response and recurrence risk in early-stage breast cancer. https://ow.ly/BYZR50XKpKV
Findings from RenaCARE, evaluating management of CKD one year after RenasightTM testing have been published in @asnpublications.bsky.social.
Results show how genetic insights informed diagnosis, prognosis and family care decisions.
https://ow.ly/cuze50XFUAH
#CKD #Natera #Renasight
Results show how genetic insights informed diagnosis, prognosis and family care decisions.
https://ow.ly/cuze50XFUAH
#CKD #Natera #Renasight
December 11, 2025 at 7:55 PM
Findings from RenaCARE, evaluating management of CKD one year after RenasightTM testing have been published in @asnpublications.bsky.social.
Results show how genetic insights informed diagnosis, prognosis and family care decisions.
https://ow.ly/cuze50XFUAH
#CKD #Natera #Renasight
Results show how genetic insights informed diagnosis, prognosis and family care decisions.
https://ow.ly/cuze50XFUAH
#CKD #Natera #Renasight
Reposted by Natera Genetics
Personalized ctDNA testing for MRD is transforming adjuvant therapy decisions in muscle-invasive bladder cancer.
Petros Grivas covers ctDNA's perioperative role, key trial data, and much more in this 30-min webinar.
Watch now: www.emjreviews.com/en-us/amj/on...
This content was funded by Natera.
Petros Grivas covers ctDNA's perioperative role, key trial data, and much more in this 30-min webinar.
Watch now: www.emjreviews.com/en-us/amj/on...
This content was funded by Natera.
December 9, 2025 at 1:20 PM
Personalized ctDNA testing for MRD is transforming adjuvant therapy decisions in muscle-invasive bladder cancer.
Petros Grivas covers ctDNA's perioperative role, key trial data, and much more in this 30-min webinar.
Watch now: www.emjreviews.com/en-us/amj/on...
This content was funded by Natera.
Petros Grivas covers ctDNA's perioperative role, key trial data, and much more in this 30-min webinar.
Watch now: www.emjreviews.com/en-us/amj/on...
This content was funded by Natera.
Attending #SABCS25? Be sure to stop by booth 1309 to meet the Natera team and discuss our latest data. Below is our full list of presentations, showcasing Signatera™ as a leader in MRD testing across early and metastatic breast cancer.
Learn more: https://ow.ly/iRP450XGmS5
Learn more: https://ow.ly/iRP450XGmS5
December 9, 2025 at 4:20 PM
Attending #SABCS25? Be sure to stop by booth 1309 to meet the Natera team and discuss our latest data. Below is our full list of presentations, showcasing Signatera™ as a leader in MRD testing across early and metastatic breast cancer.
Learn more: https://ow.ly/iRP450XGmS5
Learn more: https://ow.ly/iRP450XGmS5
Thank you to everyone who connected with us at #ASH25. We appreciated the opportunity to discuss emerging data and collaborate with colleagues.
Learn more about the value Signatera™ can offer to lymphoma patients for personalized and precise care: www.natera.com/oncology/sig...
Learn more about the value Signatera™ can offer to lymphoma patients for personalized and precise care: www.natera.com/oncology/sig...
December 9, 2025 at 3:49 PM
Thank you to everyone who connected with us at #ASH25. We appreciated the opportunity to discuss emerging data and collaborate with colleagues.
Learn more about the value Signatera™ can offer to lymphoma patients for personalized and precise care: www.natera.com/oncology/sig...
Learn more about the value Signatera™ can offer to lymphoma patients for personalized and precise care: www.natera.com/oncology/sig...
Today, Natera announced the acquisition of @foresight-dx.bsky.social. This combination brings together Foresight’s phased variant technology with Natera’s Signatera™ platform to further strengthen performance across both solid tumors and hematologic cancers.
www.natera.com/company/news...
www.natera.com/company/news...
December 5, 2025 at 12:36 PM
Today, Natera announced the acquisition of @foresight-dx.bsky.social. This combination brings together Foresight’s phased variant technology with Natera’s Signatera™ platform to further strengthen performance across both solid tumors and hematologic cancers.
www.natera.com/company/news...
www.natera.com/company/news...
We're looking forward to the ASH Annual Meeting this week. View the list of our presentations below and learn more here: https://ow.ly/bbIS50XBvGV
#ASH25 #Natera
#ASH25 #Natera
December 3, 2025 at 8:01 PM
We're looking forward to the ASH Annual Meeting this week. View the list of our presentations below and learn more here: https://ow.ly/bbIS50XBvGV
#ASH25 #Natera
#ASH25 #Natera
Kyle’s experience with stage IV colon cancer underscores the role of early detection and personalized care. With the help of Signatera™ MRD testing, Kyle’s care team identified recurrence before imaging could and took swift action.
See his full story: https://ow.ly/czIF50XAbPg
#MRDtesting #Natera
See his full story: https://ow.ly/czIF50XAbPg
#MRDtesting #Natera
December 1, 2025 at 8:30 PM
Kyle’s experience with stage IV colon cancer underscores the role of early detection and personalized care. With the help of Signatera™ MRD testing, Kyle’s care team identified recurrence before imaging could and took swift action.
See his full story: https://ow.ly/czIF50XAbPg
#MRDtesting #Natera
See his full story: https://ow.ly/czIF50XAbPg
#MRDtesting #Natera
Across roles and teams at Natera, our genetic counselors help make complex science understandable and personal. They support patients, providers and colleagues alike. Their insights drive innovation and make a difference in every strand of what we do. 🧬 Thank you to our Genetic Counselors! #Natera
November 13, 2025 at 10:35 PM
Across roles and teams at Natera, our genetic counselors help make complex science understandable and personal. They support patients, providers and colleagues alike. Their insights drive innovation and make a difference in every strand of what we do. 🧬 Thank you to our Genetic Counselors! #Natera
Thanks to everyone who attended our presentations and stopped by our booth at #KidneyWk so far. If you haven't yet, we look forward to connecting with you at booth 275!
www.natera.com/organ-health/
www.natera.com/organ-health/
November 7, 2025 at 7:52 PM
Thanks to everyone who attended our presentations and stopped by our booth at #KidneyWk so far. If you haven't yet, we look forward to connecting with you at booth 275!
www.natera.com/organ-health/
www.natera.com/organ-health/
👋 #KidneyWk, stop by booth 725 to meet our team, discuss genetics and recharge with some coffee!
ow.ly/Jsht50Xokx9 #Natera
ow.ly/Jsht50Xokx9 #Natera
November 7, 2025 at 1:18 PM
👋 #KidneyWk, stop by booth 725 to meet our team, discuss genetics and recharge with some coffee!
ow.ly/Jsht50Xokx9 #Natera
ow.ly/Jsht50Xokx9 #Natera
Anj's family history of breast cancer led her to early mammogram screenings and her diagnosis. Today, she's using Signatera™ with her care team to monitor for recurrence.
Watch her full story here: ow.ly/cpfR50Xojqr
#Natera
Watch her full story here: ow.ly/cpfR50Xojqr
#Natera
November 7, 2025 at 12:51 PM
Anj's family history of breast cancer led her to early mammogram screenings and her diagnosis. Today, she's using Signatera™ with her care team to monitor for recurrence.
Watch her full story here: ow.ly/cpfR50Xojqr
#Natera
Watch her full story here: ow.ly/cpfR50Xojqr
#Natera
Safe travels to everyone attending #KidneyWk! See you soon at booth 725.
www.natera.com/organ-health/ #Natera
www.natera.com/organ-health/ #Natera
November 6, 2025 at 11:20 PM
Safe travels to everyone attending #KidneyWk! See you soon at booth 725.
www.natera.com/organ-health/ #Natera
www.natera.com/organ-health/ #Natera
Naterans assembled Kynd Kits through Project Helping to benefit @firstdescents.bsky.social, a non-profit that provides life-changing outdoor adventures for young adults impacted by cancer and other serious health conditions. 💙💚 #TeamNatera #Natera
October 31, 2025 at 8:12 PM
Naterans assembled Kynd Kits through Project Helping to benefit @firstdescents.bsky.social, a non-profit that provides life-changing outdoor adventures for young adults impacted by cancer and other serious health conditions. 💙💚 #TeamNatera #Natera
See you soon for #KidneyWk! Stop by booth # 725 to speak to our team. See below for details on the ways we're supporting genetics in the field of nephrology.
@asnkidney.bsky.social
#Natera
@asnkidney.bsky.social
#Natera
October 29, 2025 at 9:31 PM
See you soon for #KidneyWk! Stop by booth # 725 to speak to our team. See below for details on the ways we're supporting genetics in the field of nephrology.
@asnkidney.bsky.social
#Natera
@asnkidney.bsky.social
#Natera
Join us at #NSGC25 for our presentations, events and highly anticipated resume review! Learn more in the flyer below and be sure to stop by booth #517 to speak with our team.
#Natera #GeneticCounselors #GeneticCounseling #GC
#Natera #GeneticCounselors #GeneticCounseling #GC
October 29, 2025 at 3:15 PM
Join us at #NSGC25 for our presentations, events and highly anticipated resume review! Learn more in the flyer below and be sure to stop by booth #517 to speak with our team.
#Natera #GeneticCounselors #GeneticCounseling #GC
#Natera #GeneticCounselors #GeneticCounseling #GC
New data from our PROCEED-CRC trial showed 22.5% sensitivity and 91.5% specificity for detecting advanced adenomas — precancerous polyps linked to the development of colorectal cancer. These results mark continued progress in our early cancer detection program.
www.natera.com/company/news...
www.natera.com/company/news...
October 28, 2025 at 5:58 PM
New data from our PROCEED-CRC trial showed 22.5% sensitivity and 91.5% specificity for detecting advanced adenomas — precancerous polyps linked to the development of colorectal cancer. These results mark continued progress in our early cancer detection program.
www.natera.com/company/news...
www.natera.com/company/news...
Proud to support the 4th Annual Gathering of the Wolves, hosted by Man Up To Cancer, an organization dedicated to supporting men with any kind of cancer diagnosis, providing community and resources to guide them through treatment and beyond. #Natera #ManUpToCancer
Man Up to Cancer
Man Up to Cancer
October 25, 2025 at 8:45 PM
Proud to support the 4th Annual Gathering of the Wolves, hosted by Man Up To Cancer, an organization dedicated to supporting men with any kind of cancer diagnosis, providing community and resources to guide them through treatment and beyond. #Natera #ManUpToCancer
Man Up to Cancer
Man Up to Cancer
Natera is honored to be a national sponsor of the Susan G. Komen More Than Pink Walk series. Together, we walk for hope, progress and a future without breast cancer. Thank you, Susan G. Komen, for welcoming us into this incredible community. 💗 #MoreThanPink #Natera
Susan G. Komen
Susan G. Komen
October 21, 2025 at 9:10 PM
Natera is honored to be a national sponsor of the Susan G. Komen More Than Pink Walk series. Together, we walk for hope, progress and a future without breast cancer. Thank you, Susan G. Komen, for welcoming us into this incredible community. 💗 #MoreThanPink #Natera
Susan G. Komen
Susan G. Komen
Natera has been named to @fastcompany.com’s 2025 Next Big Things in Tech list for Signatera™, our personalized MRD test that’s redefining how cancer is detected and managed. ow.ly/wFg050XblTy
#FCTechAwards #Natera
#FCTechAwards #Natera
October 21, 2025 at 4:35 PM
Natera has been named to @fastcompany.com’s 2025 Next Big Things in Tech list for Signatera™, our personalized MRD test that’s redefining how cancer is detected and managed. ow.ly/wFg050XblTy
#FCTechAwards #Natera
#FCTechAwards #Natera
Reposted by Natera Genetics
In muscle-invasive bladder cancer, ctDNA-guided atezolizumab led to longer disease-free survival (9.9 vs. 4.8 months), as well as to longer overall survival (32.8 vs. 21.1 months), than placebo among ctDNA-positive patients. Full IMvigor011 phase 3 trial results: nej.md/3WIRtEg
#ESMO25
#ESMO25
October 20, 2025 at 2:35 PM
In muscle-invasive bladder cancer, ctDNA-guided atezolizumab led to longer disease-free survival (9.9 vs. 4.8 months), as well as to longer overall survival (32.8 vs. 21.1 months), than placebo among ctDNA-positive patients. Full IMvigor011 phase 3 trial results: nej.md/3WIRtEg
#ESMO25
#ESMO25
We’re pleased to share a pivotal moment in MRD testing for Signatera™, with the New England Journal of Medicine publishing the results of IMvigor011. www.nejm.org/doi/full/10....
#ESMO25 #Natera
#ESMO25 #Natera
October 21, 2025 at 2:27 PM
We’re pleased to share a pivotal moment in MRD testing for Signatera™, with the New England Journal of Medicine publishing the results of IMvigor011. www.nejm.org/doi/full/10....
#ESMO25 #Natera
#ESMO25 #Natera
Natera’s technology will be featured across multiple presentations at #ESMO2025. See the full schedule below and stop by booth #1016 to learn more. #Natera #MRD #Signatera
@myesmo.bsky.social
@myesmo.bsky.social
October 17, 2025 at 5:31 PM
Natera’s technology will be featured across multiple presentations at #ESMO2025. See the full schedule below and stop by booth #1016 to learn more. #Natera #MRD #Signatera
@myesmo.bsky.social
@myesmo.bsky.social
Natera’s technology will be featured in 14 studies at the ESMO - European Society for Medical Oncology Congress, including 6 oral presentations. We look forward to connecting at #ESMO25 as we continue advancing personalized, MRD-guided cancer care for patients everywhere.
https://ow.ly/XJ1x50XaKc1
https://ow.ly/XJ1x50XaKc1
October 13, 2025 at 7:40 PM
Natera’s technology will be featured in 14 studies at the ESMO - European Society for Medical Oncology Congress, including 6 oral presentations. We look forward to connecting at #ESMO25 as we continue advancing personalized, MRD-guided cancer care for patients everywhere.
https://ow.ly/XJ1x50XaKc1
https://ow.ly/XJ1x50XaKc1
We're honored to support the Bottoms Up Invitational by Colorectal Cancer Alliance. This event helps increase awareness for screening, fund research and support those affected by #ColorectalCancer. Learn more at: https://ow.ly/bOio50X3ZkJ
Photo credit: Andrew H. Walker/Shutterstock
Photo credit: Andrew H. Walker/Shutterstock
October 6, 2025 at 9:05 PM
We're honored to support the Bottoms Up Invitational by Colorectal Cancer Alliance. This event helps increase awareness for screening, fund research and support those affected by #ColorectalCancer. Learn more at: https://ow.ly/bOio50X3ZkJ
Photo credit: Andrew H. Walker/Shutterstock
Photo credit: Andrew H. Walker/Shutterstock